PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Emory Eye Center, Emory University School of Medicine, Atlanta, GA, USA.\', \'Department of Medicine, Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine, Emory University School of Medicine, Atlanta, GA, USA.\', \'Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA.\', \'Department of Medicine, Division of Infectious Diseases, Emory University School of Medicine, Atlanta, GA, USA.\', \'Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, USA.\', \'Department of Neurology and Neurosurgery, Division of Neurocritical Care, Emory University School of Medicine, Atlanta, GA, USA.\', \'Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA, USA.\', \'Department of Global and Community Health, College of Health and Human Services, George Mason University, Fairfax, VA, USA.\', \'Truhlsen Eye Institute, University of Nebraska Medical Center, Omaha, NE, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1080/09273948.2021.1952278
?:hasPublicationType
?:journal
  • Ocular immunology and inflammation
is ?:pmid of
?:pmid
?:pmid
  • 34464544
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.746
?:rankingScore_hIndex
  • 46
is ?:relation_isRelatedTo_publication of
?:title
  • Retinopathy and Systemic Disease Morbidity in Severe COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all